Gary H. Lyman, MD, MPH
Advertisement
Articles by Gary H. Lyman, MD, MPH
Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Advertisement
Latest Updated Articles
- Creating Value-Based Metrics for Cancer Care: A Stakeholder-Informed, Evidence-Driven Approach
Published: April 16th 2015 | Updated:
- Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
Published: February 13th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Rural-Urban Disparities in Colorectal Cancer Screening Persist
2
Medicaid Work Rules Could Strain Hospitals: Laxmi Patel
3
Practical Applications of Cost-Effective Knee Osteoarthritis and Obesity Treatments: Elena Losina, PhD
4
Future Research Can Guide Employer, Policy Strategies to Improve Workforce Well-Being: Refat Rasul Srejon, MPH
5
